Somatic RAS mutations occur in a large proportion of sporadic RET-negative medullary thyroid carcinomas and extend to

A Boichard1, L Croux, A Al Ghuzlan

  • 1Institut Gustave Roussy, Translational Research Laboratory, 114 Rue Édouard Vaillant, 94805 Villejuif, France.

Abstract

Insights

RAS mutations are common in sporadic medullary thyroid carcinoma (MTC), occurring independently of RET mutations. Analysis should include exon 4 of RAS genes, not just hot spots.

Area of Science:

  • Oncology
  • Genetics
  • Molecular Biology

Background:

  • Medullary thyroid carcinoma (MTC) often involves RET proto-oncogene mutations.
  • RAS mutations are increasingly recognized as significant in sporadic MTC tumorigenesis.

Purpose of the Study:

  • To investigate the frequency and spectrum of RET, BRAF, and RAS mutations in MTC.
  • To determine the role of RAS mutations in sporadic MTC lacking RET alterations.

Main Methods:

  • Direct sequencing of RET, BRAF, KRAS, HRAS, and NRAS genes in 50 MTC samples.
  • Analysis included exons 2, 3, and 4 for RAS genes, and specific exons for RET and BRAF.

Main Results:

  • RET mutations were found in hereditary and sporadic MTC cases.
  • RAS mutations (HRAS, KRAS) were identified in 13 of 16 sporadic MTCs without RET mutations.
  • RAS and RET mutations were mutually exclusive; no BRAF or NRAS mutations were detected.

Conclusions:

  • RAS mutations are frequent in sporadic MTC and represent an alternative oncogenic pathway.
  • Comprehensive RAS mutation analysis, including exon 4, is crucial for sporadic MTC diagnosis.

Related Concept Videos

The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Non-LTR Retrotransposons03:18

Non-LTR Retrotransposons

As the name suggests, non-LTR retrotransposons lack the long terminal repeats characteristic of the LTR retrotransposons. Additionally, both LTR and non-LTR retrotransposons use distinct mechanisms of mobilization. Non-LTR retrotransposons are further divided into two classes - Long interspersed nuclear elements (LINEs) and short interspersed nuclear elements (SINEs), both of which occur abundantly in most mammals, including humans. Some of the active non-LTR retrotransposons in humans are L1...
Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...